UniProt ID | TNPO3_HUMAN | |
---|---|---|
UniProt AC | Q9Y5L0 | |
Protein Name | Transportin-3 | |
Gene Name | TNPO3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 923 | |
Subcellular Localization | Cytoplasm . Nucleus . | |
Protein Description | Seems to function in nuclear protein import as nuclear transport receptor. In vitro, mediates the nuclear import of splicing factor SR proteins RBM4, SFRS1 and SFRS2, by recognizing phosphorylated RS domains.. | |
Protein Sequence | MEGAKPTLQLVYQAVQALYHDPDPSGKERASFWLGELQRSVHAWEISDQLLQIRQDVESCYFAAQTMKMKIQTSFYELPTDSHASLRDSLLTHIQNLKDLSPVIVTQLALAIADLALQMPSWKGCVQTLVEKYSNDVTSLPFLLEILTVLPEEVHSRSLRIGANRRTEIIEDLAFYSSTVVSLLMTCVEKAGTDEKMLMKVFRCLGSWFNLGVLDSNFMANNKLLALLFEVLQQDKTSSNLHEAASDCVCSALYAIENVETNLPLAMQLFQGVLTLETAYHMAVAREDLDKVLNYCRIFTELCETFLEKIVCTPGQGLGDLRTLELLLICAGHPQYEVVEISFNFWYRLGEHLYKTNDEVIHGIFKAYIQRLLHALARHCQLEPDHEGVPEETDDFGEFRMRVSDLVKDLIFLIGSMECFAQLYSTLKEGNPPWEVTEAVLFIMAAIAKSVDPENNPTLVEVLEGVVRLPETVHTAVRYTSIELVGEMSEVVDRNPQFLDPVLGYLMKGLCEKPLASAAAKAIHNICSVCRDHMAQHFNGLLEIARSLDSFLLSPEAAVGLLKGTALVLARLPLDKITECLSELCSVQVMALKKLLSQEPSNGISSDPTVFLDRLAVIFRHTNPIVENGQTHPCQKVIQEIWPVLSETLNKHRADNRIVERCCRCLRFAVRCVGKGSAALLQPLVTQMVNVYHVHQHSCFLYLGSILVDEYGMEEGCRQGLLDMLQALCIPTFQLLEQQNGLQNHPDTVDDLFRLATRFIQRSPVTLLRSQVVIPILQWAIASTTLDHRDANCSVMRFLRDLIHTGVANDHEEDFELRKELIGQVMNQLGQQLVSQLLHTCCFCLPPYTLPDVAEVLWEIMQVDRPTFCRWLENSLKGLPKETTVGAVTVTHKQLTDFHKQVTSAEECKQVCWALRDFTRLFR | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MEGAKPTL -------CCCCCCHH | 10.93 | 19413330 | |
5 | Acetylation | ---MEGAKPTLQLVY ---CCCCCCHHHHHH | 49.76 | 21339330 | |
19 | Phosphorylation | YQAVQALYHDPDPSG HHHHHHHHCCCCCCC | 13.75 | 20068231 | |
59 | Phosphorylation | QIRQDVESCYFAAQT HHHHHHHHHHHHHHH | 17.61 | 27067055 | |
61 | Phosphorylation | RQDVESCYFAAQTMK HHHHHHHHHHHHHHH | 12.92 | 27067055 | |
66 | Phosphorylation | SCYFAAQTMKMKIQT HHHHHHHHHHHHHEE | 17.65 | 27067055 | |
68 | Ubiquitination | YFAAQTMKMKIQTSF HHHHHHHHHHHEECE | 40.19 | - | |
73 | Phosphorylation | TMKMKIQTSFYELPT HHHHHHEECEECCCC | 25.03 | 20873877 | |
74 | Phosphorylation | MKMKIQTSFYELPTD HHHHHEECEECCCCC | 14.95 | 20873877 | |
76 | Phosphorylation | MKIQTSFYELPTDSH HHHEECEECCCCCCC | 19.14 | 20873877 | |
80 | Phosphorylation | TSFYELPTDSHASLR ECEECCCCCCCHHHH | 63.86 | 20873877 | |
82 | Phosphorylation | FYELPTDSHASLRDS EECCCCCCCHHHHHH | 24.35 | 20873877 | |
85 | Phosphorylation | LPTDSHASLRDSLLT CCCCCCHHHHHHHHH | 20.65 | 20068231 | |
89 | Phosphorylation | SHASLRDSLLTHIQN CCHHHHHHHHHHHHH | 20.88 | 20873877 | |
92 | Phosphorylation | SLRDSLLTHIQNLKD HHHHHHHHHHHHHHC | 23.40 | 20873877 | |
190 | Ubiquitination | LLMTCVEKAGTDEKM HHHHHHHHHCCCHHH | 31.55 | - | |
291 | 2-Hydroxyisobutyrylation | VAREDLDKVLNYCRI HHHHHHHHHHHHHHH | 56.79 | - | |
355 | Ubiquitination | RLGEHLYKTNDEVIH HHCCHHHHCCHHHHH | 47.41 | - | |
501 (in isoform 5) | Phosphorylation | - | 25.94 | 28348404 | |
513 | Ubiquitination | LMKGLCEKPLASAAA HHHCCCCCHHHHHHH | 44.31 | - | |
513 | Acetylation | LMKGLCEKPLASAAA HHHCCCCCHHHHHHH | 44.31 | 25953088 | |
521 | Ubiquitination | PLASAAAKAIHNICS HHHHHHHHHHHHHHH | 43.05 | - | |
530 | Ubiquitination | IHNICSVCRDHMAQH HHHHHHHHHHHHHHH | 2.13 | 21890473 | |
554 | Phosphorylation | SLDSFLLSPEAAVGL HHHHHHCCHHHHHHH | 23.88 | - | |
594 (in isoform 3) | Ubiquitination | - | 56.35 | 21890473 | |
594 | Acetylation | VQVMALKKLLSQEPS HHHHHHHHHHCCCCC | 56.35 | 25953088 | |
594 (in isoform 2) | Ubiquitination | - | 56.35 | 21890473 | |
594 | Ubiquitination | VQVMALKKLLSQEPS HHHHHHHHHHCCCCC | 56.35 | 2189047 | |
628 (in isoform 1) | Ubiquitination | - | 36.66 | 21890473 | |
646 | Phosphorylation | QEIWPVLSETLNKHR HHHHHHHHHHHHHHC | 28.86 | 20873877 | |
648 | Phosphorylation | IWPVLSETLNKHRAD HHHHHHHHHHHHCCC | 32.05 | 20873877 | |
877 | Acetylation | RWLENSLKGLPKETT HHHHHHCCCCCCCCC | 59.22 | 25953088 | |
883 | Phosphorylation | LKGLPKETTVGAVTV CCCCCCCCCCCEEEE | 32.67 | 19690332 | |
891 | Phosphorylation | TVGAVTVTHKQLTDF CCCEEEEEHHHHHHH | 17.62 | 19690332 | |
896 (in isoform 3) | Phosphorylation | - | 33.84 | 25599653 | |
896 | Phosphorylation | TVTHKQLTDFHKQVT EEEHHHHHHHHHHCC | 33.84 | 10366588 | |
900 | Acetylation | KQLTDFHKQVTSAEE HHHHHHHHHCCCHHH | 46.59 | 23749302 | |
909 | Acetylation | VTSAEECKQVCWALR CCCHHHHHHHHHHHH | 49.39 | 25953088 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TNPO3_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TNPO3_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TNPO3_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
UBE3A_HUMAN | UBE3A | physical | 22939629 | |
ARP3_HUMAN | ACTR3 | physical | 22863883 | |
ARPC2_HUMAN | ARPC2 | physical | 22863883 | |
FEN1_HUMAN | FEN1 | physical | 22863883 | |
HNRH1_HUMAN | HNRNPH1 | physical | 22863883 | |
IPO9_HUMAN | IPO9 | physical | 22863883 | |
PFD6_HUMAN | PFDN6 | physical | 22863883 | |
PP2AA_HUMAN | PPP2CA | physical | 22863883 | |
PP2BA_HUMAN | PPP3CA | physical | 22863883 | |
TTL12_HUMAN | TTLL12 | physical | 22863883 | |
STOM_HUMAN | STOM | physical | 27173435 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
608423 | Limb-girdle muscular dystrophy 1F (LGMD1F) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-896, AND MASSSPECTROMETRY. |